[1]
D. Russo, M. Afonso, A. Moreira, J. Mendonça, and M. Abreu, “Targeting IDH1: Long-Term Efficacy and Tolerance of Ivosidenib in Advanced Chondrosarcoma”, Acta Med Port, Sep. 2026.